Azienda Ospedaliero-Universitaria di Modena clinical trials
Azienda Ospedaliero-Universitaria di Modena is the lead sponsor of 12 current clinical trials in our Italy and EU (CTIS) registers. 8 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Colchicine and Semaglutide. The most-studied condition is Hepatocellular Carcinoma.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Azienda Ospedaliero-Universitaria di Modena
10 on ClinicalTrials.govRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Azienda Ospedaliero-Universitaria di Modena in the EU trials register (CTIS)
2 trialsAuthorised or ongoing trials in the EU Clinical Trials Information System with Azienda Ospedaliero-Universitaria di Modena as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
Semaglutide for the treatment of visceral obesity in people with HIV with body mass index <30 kg/m2 and without diabetes: a randomized clinical trial to explore immune metabolism, systemic and vascular inflammation assessed with Positron Emission Tomography
2026-526738-18-00 · CTIS ↗ · Virus Diseases
Drug: Semaglutide |
Phase 2 | Authorised | Italy |
|
A RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, CLINICAL TRIAL OF COLCHICINE IN AMYOTROPHIC LATERAL SCLEROSIS (CO-ALS II)
2026-526460-20-00 · Musculoskeletal Diseases
|
Phase 2 | Authorised | Italy |
Drugs in Azienda Ospedaliero-Universitaria di Modena trials
2 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Azienda Ospedaliero-Universitaria di Modena trials
18 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 10 | 8 |
| EU register (CTIS) | 2 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Hepatocellular Carcinoma
Sponsors with the most current trials registered for this condition.
Questions about Azienda Ospedaliero-Universitaria di Modena trials
How many clinical trials does Azienda Ospedaliero-Universitaria di Modena sponsor?
Azienda Ospedaliero-Universitaria di Modena is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Italy register, and 2 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.
Are Azienda Ospedaliero-Universitaria di Modena trials recruiting?
Yes. 8 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Azienda Ospedaliero-Universitaria di Modena testing?
Its current trials name 2 drugs and biologicals as interventions. The most frequent are Colchicine (1) and Semaglutide (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.